Maricla Galetti

9PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsNoise and wave pollution processes and measurementEnvironmental biogeochemistryRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 26, 2025
Correction: Cavazzoni et al. Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer. Cancers 2020, 12, 666.

Andrea Cavazzoni, Graziana Digiacomo, Roberta Alfieri

|Dec 23, 2023
A Photoactive Supramolecular Complex Targeting PD-L1 Reveals a Weak Correlation between Photoactivation Efficiency and Receptor Expression Levels in Non-Small-Cell Lung Cancer Tumor Models.

Pietro Delcanale, Manuela Maria Alampi, Andrea Mussini

|Apr 13, 2023
Three-Dimensional Bioprinting of Organoid-Based Scaffolds (OBST) for Long-Term Nanoparticle Toxicology Investigation.

Amparo Guerrero Gerbolés, Maricla Galetti, Stefano Rossi

|Mar 11, 2023
Interaction between Occupational and Non-Occupational Arsenic Exposure and Tobacco Smoke on Lung Cancerogenesis: A Systematic Review.

Giuseppina Folesani, Maricla Galetti, Pier Giorgio Petronini

|Jan 21, 2023
A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC.

Maria Pia Adorni, Maricla Galetti, Silvia La Monica

|Dec 11, 2022
CDK4/6 Inhibition Enhances the Efficacy of Standard Chemotherapy Treatment in Malignant Pleural Mesothelioma Cells.

Rita Terenziani, Maricla Galetti, Silvia La Monica

Pageof 2

Frequent Collaborators

5 joint publications

Claudia Fumarola

5 joint publications

Roberta Alfieri

4 joint publications

Andrea Cavazzoni

4 joint publications

Silvia La Monica